Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial

出版年份 2016 全文链接

标题

作者

关键词

出版物

Volume 17, Issue 1, Pages 90-98

出版商

Elsevier BV

发表日期

2015-11-28

DOI

10.1016/s1470-2045(15)00411-8

联系作者

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started